Wyeth, Dr. Reddy's Strike Deal Over Effexor Patents

Law360, New York (April 21, 2011, 12:08 PM EDT) -- Wyeth LLC reached a deal in New Jersey federal court on Thursday with Dr. Reddy's Laboratories Ltd. over a generic version of blockbuster antidepressant and anti-anxiety drug Effexor XR.

The settlement of the suit against Dr. Reddy's is the latest in a long line of agreements Wyeth has reached to protect its hold on the market for venlafaxine HCl extended release capsules — the active ingredient in the drug.

Most recently, Orchid Chemicals & Pharmaceuticals Ltd. agreed on April 13 not to manufacture the tablets until...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.